IQVIA Holdings Inc. (LON:0JDM)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 22.61B |
| Revenue (ttm) | 11.46B |
| Net Income (ttm) | 902.89M |
| Shares Out | n/a |
| EPS (ttm) | 5.05 |
| PE Ratio | 25.05 |
| Forward PE | 14.26 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 94 |
| Average Volume | 1,863 |
| Open | 182.20 |
| Previous Close | 182.55 |
| Day's Range | 181.31 - 183.48 |
| 52-Week Range | 134.83 - 252.90 |
| Beta | n/a |
| RSI | 50.49 |
| Earnings Date | Jul 21, 2025 |
About Activision Blizzard
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ... [Read more]
Financial Performance
In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.
Financial StatementsNews
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led ... Full story available on Benzinga.com
IQVIA: Q2 Earnings Exceeded My Expectations
IQVIA Holdings Inc.'s Q1 results highlighted strong profitability, robust TAS growth, and a healthy backlog, reaffirming its leadership in healthcare data and analytics. Despite sector headwinds, I re...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2210426196-0bff128f07b24be986d18f8c0e4bc68d.jpg)
IQVIA Leads S&P 500 Gainers on Better-Than-Expected Earnings
IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped estimates.
IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript
IQVIA Holdings Inc. 2025 Q2 - Results - Earnings Call Presentation
IQVIA beats quarterly estimates on resilient demand for healthcare analytics
Contract research firm IQVIA Holdings posted second-quarter profit and revenue above Wall Street expectations on Tuesday, as demand rose for its healthcare data and analytics services, sending shares ...
IQVIA Reports Second-Quarter 2025 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
Preview: IQVIA Hldgs's Earnings
IQVIA Hldgs (NYSE: IQV) will release its quarterly earnings report on Tuesday, 2025-07-22. Here's a brief overview for investors ahead of the announcement. Analysts anticipate IQVIA Hldgs to report a...
IQVIA: Competition Is Creating More Challenges Over The Long Haul
I rate IQVIA as a hold due to long-term competitive threats, particularly from one player, and concerns about capital allocation and high debt. IQVIA's business model is solid, but declining gross mar...
Is IQVIA Hldgs Gaining or Losing Market Support?
IQVIA Hldgs's (NYSE: IQV) short percent of float has risen 29.88% since its last report. The company recently reported that it has 9.33 million shares sold short , which is 6.26% of all regular share...
IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA Launches New AI Agents for Life Sciences and Healthcare
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?
IQVIA (IQV) is currently in Phase 18 of its 18-Phase Adhishthana Cycle. On the surface, the stock might appear poised for a new move, but when analyzed through a multi-timeframe lens using the Adhisht...
IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?
IQVIA (IQV) is currently in Phase 18 of its 18-Phase Adhishthana Cycle. On the surface, the stock might appear poised for a new move, but when analyzed through a multi-timeframe lens using the Adhisht...
IQVIA Announces Pricing of Senior Notes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,00...
IQVIA Announces Offering of Senior Notes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 thr...
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of 2026 AUSTIN, Texas , May 27, 2025 /P...
P/E Ratio Insights for IQVIA Hldgs
In the current market session, IQVIA Hldgs Inc. (NYSE: IQV) price is at $139.70, after a 1.20% increase. However, over the past month, the stock fell by 10.72% , and in the past year, by 39.57% . Sha...
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA: Q1 Earnings Support Steady Optimism
IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions segment, despite market pessimism. The company's profitability remains robus...
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank...
IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript
IQVIA Reports First-Quarter 2025 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and heal...